Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2020-06-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2020/6/e15851 |
id |
doaj-f3ef6c3dc93745a4ac9ae3b47c4465b7 |
---|---|
record_format |
Article |
spelling |
doaj-f3ef6c3dc93745a4ac9ae3b47c4465b72021-05-03T02:53:40ZengJMIR PublicationsJMIR Research Protocols1929-07482020-06-0196e1585110.2196/15851Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort StudySmith, AlexanderBains, NatalieCopeland, LaurenPennington, AnnaCarter, BenHewitt, Jonathan BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning decisions, planning care, and adjusting to life after stroke. ObjectiveThe primary aim of the Morbidity PRevalence Estimate In StrokE (MORe PREcISE) study is to determine the prevalence of morbidity secondary to a stroke, predictors of morbidity, and trends in quality of life and functional status using patient-reported outcomes, cognitive and functional assessments. MethodsA total of 500 participants will be recruited across Wales and England within 14 days following an admission to a stroke unit for either an ischemic or hemorrhagic stroke as part of a multicenter cohort study. Participants are assessed at baseline ≤14 days poststroke and subsequently at 90 (± 14) days and 180 (± 14) days poststroke. At each time point, data will be collected relating to the following domains: participant demographics, routine clinical, patient reported, cognitive status, emotional well-being, and functional ability. ResultsRecruitment commenced in October 2018 with 20 sites opened as of September 2019 and was closed on October 31, 2019. ConclusionsThe primary outcome is the prevalence of morbidity at 6 months secondary to a stroke. Further analysis will consider temporal changes in the health-related domains to describe trends among baseline, 3-, and 6-month time points. Trial RegistrationClinicalTrials.gov NCT03605381; https://clinicaltrials.gov/ct2/show/NCT03605381 International Registered Report Identifier (IRRID)DERR1-10.2196/15851https://www.researchprotocols.org/2020/6/e15851 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Smith, Alexander Bains, Natalie Copeland, Lauren Pennington, Anna Carter, Ben Hewitt, Jonathan |
spellingShingle |
Smith, Alexander Bains, Natalie Copeland, Lauren Pennington, Anna Carter, Ben Hewitt, Jonathan Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study JMIR Research Protocols |
author_facet |
Smith, Alexander Bains, Natalie Copeland, Lauren Pennington, Anna Carter, Ben Hewitt, Jonathan |
author_sort |
Smith, Alexander |
title |
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study |
title_short |
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study |
title_full |
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study |
title_fullStr |
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study |
title_full_unstemmed |
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study |
title_sort |
morbidity prevalence estimate at 6 months following a stroke: protocol for a cohort study |
publisher |
JMIR Publications |
series |
JMIR Research Protocols |
issn |
1929-0748 |
publishDate |
2020-06-01 |
description |
BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning decisions, planning care, and adjusting to life after stroke.
ObjectiveThe primary aim of the Morbidity PRevalence Estimate In StrokE (MORe PREcISE) study is to determine the prevalence of morbidity secondary to a stroke, predictors of morbidity, and trends in quality of life and functional status using patient-reported outcomes, cognitive and functional assessments.
MethodsA total of 500 participants will be recruited across Wales and England within 14 days following an admission to a stroke unit for either an ischemic or hemorrhagic stroke as part of a multicenter cohort study. Participants are assessed at baseline ≤14 days poststroke and subsequently at 90 (± 14) days and 180 (± 14) days poststroke. At each time point, data will be collected relating to the following domains: participant demographics, routine clinical, patient reported, cognitive status, emotional well-being, and functional ability.
ResultsRecruitment commenced in October 2018 with 20 sites opened as of September 2019 and was closed on October 31, 2019.
ConclusionsThe primary outcome is the prevalence of morbidity at 6 months secondary to a stroke. Further analysis will consider temporal changes in the health-related domains to describe trends among baseline, 3-, and 6-month time points.
Trial RegistrationClinicalTrials.gov NCT03605381; https://clinicaltrials.gov/ct2/show/NCT03605381
International Registered Report Identifier (IRRID)DERR1-10.2196/15851 |
url |
https://www.researchprotocols.org/2020/6/e15851 |
work_keys_str_mv |
AT smithalexander morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy AT bainsnatalie morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy AT copelandlauren morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy AT penningtonanna morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy AT carterben morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy AT hewittjonathan morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy |
_version_ |
1721485043842416640 |